Zemplar Injection, Solution
Product Images NDC 0074-4637
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Zemplar (NDC 0074-4637). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Zemplar Injection Spl 02
Zemplar Injection Spl 03
Zemplar Injection Spl 04
Zemplar Injection Spl 05
Zemplar Injection Spl 06
Zemplar Injection Spl 07
Zemplar Injection Spl 08
Zemplar Injection Spl 09
Zemplar Injection Spl 0a
Zemplar Injection Spl 0b
This is a description of a medication in a single-dose vial. The medication is called Zemplar and it is an injection used for intravenous use. The vial contains 1 milliliter of the medication with a concentration of 5 milligrams per milliliter. The manufacturer of the medication is AbbVie Inc. The text also includes a code number "NOCOO74-1658.01" and instructions to discard any unused portion.*
Zemplar Injection Spl 0c
Zemplar Injection Spl 0d
The text is a description of ZemplarĀ® Injection, a medication containing paricalcitol in a single-dose vial of 1mL and a concentration of 2 meg/mL for intravenous use only. The label includes the National Drug Code (NDC) and indicates that this medication is available only by prescription. The manufacturer is identified as Abbie Inc, located in Chicago, IL, USA, with the product originating from Ireland. The label also includes a unique identifier number (8021428) and instructions to discard any unused portion of the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.